Featured Research

from universities, journals, and other organizations

NIH Clinical Center Study Demonstrates Dangerous Interaction Between St. John's Wort And An HIV Protease Inhibitor

Date:
February 15, 2000
Source:
National Institute Of Allergy And Infectious Diseases
Summary:
Researchers at the National Institutes of Health Clinical Center have demonstrated that a widely used herbal product--St. John's wort--could significantly compromise the effectiveness of an antiviral drug often prescribed to treat HIV infection.

Researchers at the National Institutes of Health Clinical Center have demonstrated that a widely used herbal product--St. John's wort--could significantly compromise the effectiveness of an antiviral drug often prescribed to treat HIV infection. The findings are detailed in the Feb. 12 issue of The Lancet.

"When St. John's wort and the protease inhibitor indinavir are taken together, the levels of indinavir in the blood drop dramatically," explained the study’s principal investigator, clinical pharmacokineticist Dr. Stephen Piscitelli of the NIH Clinical Center’s Pharmacy Department. "When the body eliminates the antriviral drug too quickly, there can be a loss of therapeutic benefit."

AIDS research clinician Dr. Judith Falloon of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), collaborated on the study. "St. John's wort's effects on indinavir concentrations are large enough to be clinically significant," she said. "Patients and health-care professionals need to be aware of this interaction. Most people taking medications to treat HIV infection should avoid using St. John's wort."

The NIH Clinical Center study, conducted among eight healthy volunteers, first measured the amount in the body of the drug indinavir when taken alone. Next, study participants were given only St. John’s wort for two weeks. Finally, indinavir and St. John’s wort were given together.

"The results were dramatically conclusive," Piscitelli noted. "All the participants showed a marked drop in blood levels of indinavir after taking St. John's wort. The drop ranged from 49 percent to 99 percent."

"It's vital that we understand how drugs and herbal products interact," said Dr. John I. Gallin, Clinical Center director. "This research is important because it demonstrates that a common agent such as St. John's wort may have unsuspected adverse effects on the function of a drug essential to the health of a very vulnerable population."

Indinavir belongs to a class of drugs known as protease inhibitors. These drugs are among the most potent agents available for treating HIV infection and have been shown to prolong survival and slow the progression of the disease.

Substances in both St. John's wort and in indinavir are thought to share a metabolic pathway, which suggested the probability of the drugs’ interaction, Piscitelli said. The active ingredient in St. John's wort is suspected to induce drug metabolism, which revs up the rate the liver eliminates indinavir from the body.

Consequently, there's not enough indinavir in the blood to do the job it's designed to do. "The low blood levels also can lead to drug resistance," said Piscitelli, who heads the Clinical Pharmacokinetics Research Laboratory at the NIH hospital. "Resistance to indinavir can decrease the response to other protease inhibitors." They include nelfinavir, amprenavir, ritonavir, and saquinavir.

"Many people think that herbal products like St. John's wort are safe, but there can be dangerous interactions when taken with other medications prescribed to treat medical conditions," added Piscitelli. "This study demonstrates how dangerous that interaction can be and how important it is for patients to keep their physician and pharmacist informed about any use of herbal products."Other collaborators on the study included Dr. Aaron Burstein and Raul Alfaro from the Clinical Center Pharmacy Department and Doreen Chaitt from NIAID. ###

The Warren Grant Magnuson Clinical Center and NIAID are components of the National Institutes of Health (NIH). The Clinical Center is the clinical research hospital for NIH. Through clinical research, physicians and scientists translate laboratory discoveries into better treatments, therapies and interventions to improve the nation's health. NIAID conducts and supports research to prevent, diagnose and treat illnesses such as HIV disease and other sexually transmitted diseases, tuberculosis, malaria, asthma and allergies. NIH is an agency of the U.S. Department of Health and Human Services.


Story Source:

The above story is based on materials provided by National Institute Of Allergy And Infectious Diseases. Note: Materials may be edited for content and length.


Cite This Page:

National Institute Of Allergy And Infectious Diseases. "NIH Clinical Center Study Demonstrates Dangerous Interaction Between St. John's Wort And An HIV Protease Inhibitor." ScienceDaily. ScienceDaily, 15 February 2000. <www.sciencedaily.com/releases/2000/02/000214101959.htm>.
National Institute Of Allergy And Infectious Diseases. (2000, February 15). NIH Clinical Center Study Demonstrates Dangerous Interaction Between St. John's Wort And An HIV Protease Inhibitor. ScienceDaily. Retrieved October 23, 2014 from www.sciencedaily.com/releases/2000/02/000214101959.htm
National Institute Of Allergy And Infectious Diseases. "NIH Clinical Center Study Demonstrates Dangerous Interaction Between St. John's Wort And An HIV Protease Inhibitor." ScienceDaily. www.sciencedaily.com/releases/2000/02/000214101959.htm (accessed October 23, 2014).

Share This



More Health & Medicine News

Thursday, October 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Fears Keep Guinea Hospitals Empty

Ebola Fears Keep Guinea Hospitals Empty

AP (Oct. 23, 2014) Fears of Ebola are keeping doctors and patients alike away from hospitals in the West African nation of Guinea. (Oct. 23) Video provided by AP
Powered by NewsLook.com
Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Working Mother (Oct. 22, 2014) Is your child ready? Video provided by Working Mother
Powered by NewsLook.com
U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

Newsy (Oct. 22, 2014) Now that the U.S. is restricting travel from West Africa, some are dropping questions about a travel ban and instead asking about visa bans. Video provided by Newsy
Powered by NewsLook.com
More People Diagnosed With TB In 2013, But There's Good News

More People Diagnosed With TB In 2013, But There's Good News

Newsy (Oct. 22, 2014) The World Health Organizations says TB numbers rose in 2013, but it's partly due to better detection and more survivors. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins